Chromatin Regulator SMARCA4 Is Essential for MHV-Induced Inflammatory Cell Death, PANoptosis

R K Subbarao Malireddi1, Thirumala-Devi Kanneganti1

  • 1Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

Viruses
|August 29, 2024
PubMed

Insights

Researchers identified SMARCA4 as a key factor in PANoptosis, a form of inflammatory cell death, during beta-coronavirus (β-CoV) infection. Inhibiting SMARCA4 may offer new therapeutic strategies for severe viral diseases.

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • The innate immune system is crucial for defending against beta-coronaviruses (β-CoVs), including SARS-CoV-2.
  • While essential for viral clearance, excessive innate immune activation and inflammatory cell death can lead to severe pathology like cytokine storm.
  • PANoptosis, a specific inflammatory cell death pathway, is implicated in viral infection pathology.

Purpose of the Study:

  • To identify host factors regulating inflammatory cell death during β-CoV infection.
  • To understand the molecular mechanisms underlying PANoptosis triggered by β-CoVs.
  • To explore potential therapeutic targets for mitigating β-CoV-induced disease severity.

Main Methods:

  • Conducted a cell death-based CRISPR screen using mouse hepatitis virus (MHV), a β-CoV, as a trigger.
  • Analyzed host molecules essential for inflammatory cell death.
  • Utilized gRNA-mediated deletion of the identified gene in macrophages to assess its role in MHV-induced cell death.

Main Results:

  • Identified SMARCA4, a chromatin regulator, as a host factor required for PANoptosis in response to MHV infection.
  • Demonstrated that deletion of SMARCA4 significantly inhibited MHV-induced PANoptotic cell death in macrophages.
  • Provided evidence for SMARCA4's role in regulating inflammatory cell death pathways during viral infection.

Conclusions:

  • SMARCA4 is a critical host regulator of PANoptosis during β-CoV infection.
  • Targeting SMARCA4 may represent a novel therapeutic strategy for treating β-CoV infections and associated inflammatory pathologies.
  • Findings have potential clinical implications for advancing treatment strategies against β-CoVs and other viral infections.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K